AIHacker Noonabout 7 hours ago
AI Drug Discovery Hits Regulatory Borders
39 min read
AI-designed drug rentosertib showed +98.4 mL lung capacity gain in a Phase IIa IPF trial, marking the first clean clinical proof for a machine-created medicine. The FDA approved vepdegestrant (Veppanu) on May 1, 2026, the first PROTAC degrader, for ESR1-mutated breast cancer.
Level
Hype check
Tap to vote and see what everyone thinks.
